ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Tryptamine Therapeutics Ltd
0.034
0.000
成交量：
- -
成交額：
- -
市值：
5,472.33萬
市盈率：
-8.72
高：
0.034
開：
0.034
低：
0.034
收：
0.034
52周最高：
0.050
52周最低：
0.027
股本：
16.10億
流通股本：
8.78億
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-0.004
每股收益(LYR):
-0.004
淨資產收益率：
-92.06%
總資產收益率：
-45.59%
市淨率：
9.18
市盈率(LYR):
-8.79
資料載入中...
總覽
公司
新聞資訊
公告
泰普醫療強化臨床開發團隊 關鍵人事任命助推TRP-8803研發進程
华尔街洞察
·
2025/07/16
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TYP.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"TYP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TYP.AU\",,,,,undefined,":{"symbol":"TYP.AU","market":"AU","secType":"STK","nameCN":"Tryptamine Therapeutics Ltd","latestPrice":0.034,"timestamp":1773982800000,"preClose":0.034,"halted":8,"volume":0,"delay":0,"changeRate":0,"nameEN":"Tryptamine Therapeutics Ltd","floatShares":878046607,"shares":1609510143,"eps":-0.0039,"marketStatus":"休市中","change":0,"latestTime":"03-20 16:00:00 AEDT","open":0.034,"high":0.034,"low":0.034,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0039,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1774220400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.034,"openAndCloseTimeList":[[1773961200000,1773982800000]],"volumeRatio":0,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TYP.AU","preClose":0.036,"auctionPrice":0.035,"auctionVolume":199402,"auction":3,"marketStatus":"盘后竞价","timestamp":1763614835294}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TYP.AU\",,,,,undefined,":{"symbol":"TYP.AU","floatShares":878046607,"roa":"-45.59%","roe":"-92.06%","lyrEps":-0.003868,"shares":1609510143,"dividePrice":0,"high":0.034,"amplitude":0,"preClose":0.034,"low":0.034,"week52Low":0.027,"pbRate":"9.18","psRate":"34.60","week52High":0.05,"institutionHeld":0,"latestPrice":0.034,"eps":-0.0039,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.0039,"open":0.034},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TYP.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-11-21","symbol":"TYP.AU","oldSymbol":"TYP","defaultRemindTime":1763679600000,"newSymbol":"ENP.AU","exchange":"ASX","type":"symbolChange","dateTimestamp":1763643600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TYP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TYP.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1129418081","title":"泰普醫療強化臨床開發團隊 關鍵人事任命助推TRP-8803研發進程","url":"https://stock-news.laohu8.com/highlight/detail?id=1129418081","media":"华尔街洞察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129418081?lang=zh_tw&edition=fundamental","pubTime":"2025-07-16 07:15","pubTimestamp":1752621326,"startTime":"0","endTime":"0","summary":"澳大利亚生物医药企业泰普医疗近日宣布关键人事变动，旨在加速其核心候选药物TRP-8803的临床开发进程。市场分析人士指出，此次人事布局正值TRP-8803准备进入Ⅱb期临床试验的关键节点。团队将着力优化TRP-8803的临床开发策略，最大限度释放该候选药物的治疗潜力。根据最新研发时间表，TRP-8803的剂量扩展研究预计将于2026年第一季度完成患者入组。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","TYP.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}